Sarcoma  >>  Yutuo (zimberelimab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yutuo (zimberelimab) / Arcus Biosci, Gilead
NCT04999761: AB122 Platform Study

Recruiting
1
715
Japan
AB122, TAS-116, TAS-120, TAS-115, TAS-102, Ramucirumab, Bevacizumab
Taiho Pharmaceutical Co., Ltd.
Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Non-small Cell Lung Cancer, Gastric Cancer, Alveolar Soft Part Sarcoma
05/26
05/26

Download Options